Researchers from the University of Sheffield in the United Kingdom have found that detecting diminished dopamine firing cells inside the brain with MRI technology may identify Alzheimer's earlier than traditional methods.

A cheaper alternative to x-ray imaging could increase optical mammography (OM) sensitivity by as much as 1,000-fold while minimizing ionizing radiation exposure in patients undergoing breast cancer screenings, the Optical Society announced this month.

Hologic announced that it has gained FDA approval for two new additions to the company’s 3Dimensions breast tomosynthesis system.

Siemens Healthineers announced that the FDA has cleared its MAMMOMAT Revelation mammography system.

The FDA has cleared MAMMOMAT Revelation, a premium mammography platform from Siemens Healthineers with the new InSpect integrated specimen imaging tool and the new HD breast biopsy solution for one-click targeting of suspicious areas. These and other features are designed to expand precision medicine and improve the patient experience.

Latest breast cancer screening improvements launched as company marks installation of more than 5,000 3D Mammography™ systems throughout the United States.

When Adam Stern, MD, staff psychiatrist at Beth Israel Deaconess Medical Center, was diagnosed with an aggressive form of cancer in his left kidney he suddenly had a heightened awareness of his normal body sensations, which he termed "onco-anxiety."

A newly developed imaging instrument which may improve the sensitivity of optical mammography will be presented by Italian researchers at the OSA Biophotonics Congress: Biomedical Optics meeting this April in Hollywood, Florida, according to a press release from The Optical Society.